Effects of pinostrobin on estrogen metabolism and estrogen receptor transactivation

Cancer Lett. 2000 Aug 1;156(1):37-44. doi: 10.1016/s0304-3835(00)00435-3.

Abstract

The interaction between the estrogen receptor and 5-hydroxy-7-methoxyflavanone (pinostrobin) was studied in the presence or absence of estradiol or dehydroepiandrosterone sulfate (DHEAS), respectively, using a stably transfected human breast cancer cell line (MVLN). We also evaluated its action on the proliferation in estrogen-dependent (MCF-7) human breast cancer cells in the same conditions than the estrogen receptor assay. On the other hand pinostrobin was evaluated for their effects on the human placental aromatase, 3beta-hydroxysteroid dehydrogenase Delta(4)/Delta(5) isomerase and 17beta-hydroxysteroid dehydrogenase activities. Pinostrobin did not possess antiestrogenic activity but presented anti-aromatase activity and decreased the growth of MCF-7 cells induced by DHEAS and E(2). This study provides particularly evidence of the potential biological interest of pinostrobin among the flavonoids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Aromatase Inhibitors
  • Cell Division / drug effects
  • Dehydroepiandrosterone Sulfate / pharmacology
  • Estrogens / metabolism*
  • Female
  • Flavanones*
  • Flavonoids / pharmacology*
  • Humans
  • Hydroxysteroid Dehydrogenases / antagonists & inhibitors
  • Receptors, Estrogen / drug effects*
  • Receptors, Estrogen / metabolism
  • Transcriptional Activation / drug effects*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents, Phytogenic
  • Aromatase Inhibitors
  • Estrogens
  • Flavanones
  • Flavonoids
  • Receptors, Estrogen
  • Dehydroepiandrosterone Sulfate
  • Hydroxysteroid Dehydrogenases
  • pinostrobin